Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies

Eur J Immunol. 1996 May;26(5):1103-9. doi: 10.1002/eji.1830260522.


The complement activation fragment C5a was recently shown to induce interleukin (IL)-6 synthesis by peripheral blood mononuclear cells. To understand better the role of C5a in cytokine regulation in vivo, we investigated the effects of complement depletion by cobra venom factor (CVF) or of anti-C5a monoclonal antibodies (mAb) on IL-6 generation in an animal model of septic shock. Complement-depleted pigs which were subsequently challenged with Escherichia coli generated significantly (p < 0.05) less IL-6 during the 6-h observation period than complement-sufficient controls. To address specifically the role of C5a in IL-6 regulation, we produced a C5a(57-74) peptide-specific mAb (T13/9) which neutralizes the bioactivity of porcine C5a. The mAb T13/9 does not cross-react with the precursor protein C5. The pretreatment of pigs with anti-C5a mAb T13/9 prior to the induction of sepsis resulted in a decrease of over 75% in serum IL-6 bioactivity compared to control animals (p < 0.0001). These results indicate a role for C5a in the modulation of IL-6 synthesis in Gram-negative bacteremia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antibodies, Monoclonal / chemistry
  • Antibodies, Monoclonal / pharmacology*
  • Antibody Specificity
  • Complement C5a / immunology*
  • Disease Models, Animal
  • Elapid Venoms / pharmacology
  • Interleukin-6 / antagonists & inhibitors*
  • Interleukin-6 / biosynthesis*
  • Interleukin-6 / blood
  • Mice
  • Mice, Inbred BALB C
  • Molecular Sequence Data
  • Shock, Septic / blood
  • Shock, Septic / etiology
  • Shock, Septic / immunology*
  • Swine


  • Antibodies, Monoclonal
  • Elapid Venoms
  • Interleukin-6
  • cobra venom factor
  • Complement C5a